These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33788745)

  • 1. Risk Factors for Venous Thromboembolism in Patients With Small Cell Lung Cancer.
    Dimakakos E; Livanios K; Vathiotis I; Gomatou G; Gkiozos I; Kotteas E; Kainis E; Syrigos K
    Anticancer Res; 2021 Mar; 41(3):1523-1528. PubMed ID: 33788745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Retrospective Study on Efficacy and Safety of Rivaroxaban and Dalteparin for Long-Term Treatment of Venous Thromboembolism in Patients with Lung Cancer.
    Lee JH; Hyun DG; Choi CM; Lee JC; Kim WS; Oh YM; Lee SD; Lee JS
    Respiration; 2019; 98(3):203-211. PubMed ID: 31096241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence of venous thromboembolism among patients with primary lung cancer.
    Chew HK; Davies AM; Wun T; Harvey D; Zhou H; White RH
    J Thromb Haemost; 2008 Apr; 6(4):601-8. PubMed ID: 18208538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).
    Kuderer NM; Poniewierski MS; Culakova E; Lyman GH; Khorana AA; Pabinger I; Agnelli G; Liebman HA; Vicaut E; Meyer G; Shepherd FA
    Oncologist; 2018 Feb; 23(2):247-255. PubMed ID: 28951500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism in non-small cell lung cancer patients who underwent surgery after induction therapy.
    Kaminuma Y; Tanahashi M; Suzuki E; Yoshii N; Niwa H
    Gen Thorac Cardiovasc Surg; 2020 Oct; 68(10):1156-1162. PubMed ID: 32274676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolism risk factors in Chinese non-small cell lung cancer patients.
    Wang Z; Yan HH; Yang JJ; Wang BC; Chen HJ; Zhou Q; Xu CR; Jiang BY; Wu YL
    Support Care Cancer; 2015 Mar; 23(3):635-41. PubMed ID: 25155313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of the neutrophil-lymphocyte ratio in venous thromboembolism patients with lung cancer.
    Go SI; Lee A; Lee US; Choi HJ; Kang MH; Kang JH; Jeon KN; Park MJ; Kim SH; Lee GW
    Lung Cancer; 2014 Apr; 84(1):79-85. PubMed ID: 24524817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism in patients with severe lung cancer: a narrative review.
    Zheng LX; Li L; Huang JH; Mai YM; Chen C; Dong JH; Xu ZY; Li WF; Chen XR
    Ann Palliat Med; 2021 Jun; 10(6):6957-6967. PubMed ID: 34118860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of risk factors for venous thromboembolism and evaluation of Khorana venous thromboembolism risk assessment in Japanese lung cancer patients.
    Hiraide M; Shiga T; Minowa Y; Nakano Y; Yoshioka H; Suzuki K; Yasuda C; Takahashi H; Hama T
    J Cardiol; 2020 Jan; 75(1):110-114. PubMed ID: 31416782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk Factors Associated with Venous Thromboembolism after Lung Cancer Surgery: A Single-center Study].
    Cui S; Li H; Tian B; Song C; Hu B
    Zhongguo Fei Ai Za Zhi; 2018 Oct; 21(10):753-760. PubMed ID: 30309426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Could venous thromboembolism and major bleeding be indicators of lung cancer mortality? A nationwide database study.
    Howlett J; Benzenine E; Cottenet J; Foucher P; Fagnoni P; Quantin C
    BMC Cancer; 2020 May; 20(1):461. PubMed ID: 32448219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence, risk factors, and prognosis of recurrent venous thromboembolism (VTE) in patients with advanced solid cancers receiving anticoagulation therapy after the diagnosis of index VTE.
    Yhim HY; Jang MJ; Kwak JY; Yim CY; Choi WI; Lee YC; Lee JO; Lee KW; Bang SM; Kim SH; Kim YK; Chang HJ; Oh D;
    Thromb Res; 2013 Apr; 131(4):e133-40. PubMed ID: 23399441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caprini venous thromboembolism risk assessment permits selection for postdischarge prophylactic anticoagulation in patients with resectable lung cancer.
    Hachey KJ; Hewes PD; Porter LP; Ridyard DG; Rosenkranz P; McAneny D; Fernando HC; Litle VR
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):37-44.e1. PubMed ID: 26386868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk factors of lung cancer complicated with symptomatic venous thromboembolism].
    Gong CY; Li ZW; Zhou DX; Yan H; Bao J; Ye RJ; Cao ZL; Gao ZC; Mu XL
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jun; 39(6):454-8. PubMed ID: 27289575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors of Venous Thromboembolism in Patients With Lung Cancer Before Surgery: A Case Control Study.
    Zhang F; Liu L; Sha Y
    Cancer Control; 2022; 29():10732748221127826. PubMed ID: 36223407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk prediction of venous thromboembolism in non-small cell lung cancer patients based on COMPASS-CAT risk assessment model].
    Wang YF; Ma F; Liu BL; Yang K; Li JL; Yu L
    Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):340-345. PubMed ID: 32375452
    [No Abstract]   [Full Text] [Related]  

  • 17. Incidence of venous thromboembolism and discriminating capacity of Khorana score in lung cancer patients treated with immune checkpoint inhibitors.
    Alma S; Eloi D; Léa V; Julie C; Valérie M; Pierre G; Hilgers W; Philippe G; Christine Z; Philippe D
    J Thromb Thrombolysis; 2022 Aug; 54(2):287-294. PubMed ID: 35396660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy.
    Moik F; Chan WE; Wiedemann S; Hoeller C; Tuchmann F; Aretin MB; Fuereder T; Zöchbauer-Müller S; Preusser M; Pabinger I; Ay C
    Blood; 2021 Mar; 137(12):1669-1678. PubMed ID: 33067632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of adjunctive anticoagulation in patients with lung cancer without indication for anticoagulants: a systematic review and meta-analysis.
    Zhang J; Zhang YL; Ma KX; Qu JM
    Thorax; 2013 May; 68(5):442-50. PubMed ID: 23321607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism events after breast reconstructions with DIEP free flaps in 192 consecutive case.
    Modarressi A; Schettini AV; Rüegg EM; Pittet-Cuénod B
    Ann Chir Plast Esthet; 2018 Feb; 63(1):11-19. PubMed ID: 29221853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.